|
Volumn 21, Issue 12, 2001, Pages 1031-1038
|
Induction of tolerance to recombinant therapeutic proteins
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA INTERFERON;
BOVINE SERUM ALBUMIN;
HUMAN SERUM ALBUMIN;
IMMUNOGLOBULIN G;
IMMUNOGLOBULIN M;
RECOMBINANT ALPHA2A INTERFERON;
RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
RECOMBINANT PROTEIN;
ANIMAL EXPERIMENT;
ANTIBODY RESPONSE;
ANTIBODY SPECIFICITY;
ARTICLE;
CONTROLLED STUDY;
DOSE RESPONSE;
DOSE TIME EFFECT RELATION;
GRANULOCYTE;
HUMAN;
MACROPHAGE;
MALE;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN CONTENT;
ADMINISTRATION, INTRANASAL;
ANIMALS;
DRUG TOLERANCE;
GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT;
IMMUNOGLOBULIN G;
IMMUNOGLOBULIN M;
INJECTIONS, SUBCUTANEOUS;
INTERFERON ALFA-2A;
INTERFERON TYPE I, RECOMBINANT;
MALE;
MICE;
MICE, INBRED BALB C;
NASAL MUCOSA;
RECOMBINANT PROTEINS;
ANIMALIA;
BOVINAE;
|
EID: 0035703580
PISSN: 10799907
EISSN: None
Source Type: Journal
DOI: 10.1089/107999001317205150 Document Type: Article |
Times cited : (13)
|
References (17)
|